SAMSARA BIOCAPITAL, LLC
PALO ALTO, CA · CIK 1744967 · 13F filing filed 2023-08-14
SEC-registered investment adviser since 2018 · limited liability company
- Assets managed$2.2bn
- Staff31 · 22 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds3 · $2.3bn gross assets
- Websitesamsaracap.com
- Form ADV · 2026-06-26SEC adviser record
- Kindventure
- Others nearbyPalo Alto, CA
As an employer
- Private fundsventure capital 3
US visa salary filings
- Filings FY20242
- Median salary offered$187,500
- Middle half$181,250 – $193,750
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Senior AssociatePalo Alto, CA | 2 | $187,500 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Samsara BioCapital, LLC.
$569.7m
reported value
+17.8% vs Q1 2023
47positions
79.1%in top 10
2 new
1 added
9 reduced
11 sold out
vs Q1 2023
Holdings, Q2 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CHINOOK THERAPEUTICS INC ADRO | $198.3m34.81% | Unchanged |
| MINERALYS THERAPEUTICS INC MLYS | $77.1m13.52% | Unchanged |
| ACELYRIN INC COM | $47.2m8.28% | New |
| SCHOLAR ROCK HLDG CORP SRRK | $34.7m6.09% | Unchanged |
| GRAPHITE BIO INC GRPH | $22.0m3.86% | Unchanged |
| ARCELLX INC ACLX | $19.4m3.41% | Reduced -295.7k |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $15.9m2.80% | Reduced -441.9k |
| ZYMEWORKS INC ZYME | $12.6m2.21% | Reduced -161.8k |
| IVERIC BIO INC OPHT | $12.1m2.13% | Reduced -378.7k |
| LYRA THERAPEUTICS INC LYRA | $11.4m2.01% | Added +1.0m |
| HILLEVAX INC COM | $10.3m1.81% | Reduced -10.6k |
| DICE THERAPEUTICS INC COM | $9.4m1.65% | Unchanged |
| SUTRO BIOPHARMA INC COM | $7.8m1.37% | Unchanged |
| VERONA PHARMA PLC VRNA | $7.3m1.29% | Reduced -347.5k |
| ACLARIS THERAPEUTICS INC ACRS | $7.2m1.27% | Unchanged |
| INTERCEPT PHARMACEUTICALS IN ICPT | $7.1m1.24% | Unchanged |
| PRIME MEDICINE INC PRME | $6.9m1.21% | Unchanged |
| NKARTA INC NKTX | $6.3m1.10% | Unchanged |
| PEPGEN INC PEPG | $5.8m1.02% | Unchanged |
| RHYTHM PHARMACEUTICALS INC RYTM | $5.7m1.00% | Unchanged |
| IMMUNOCORE HLDGS PLC IMCR | $4.9m0.85% | Unchanged |
| IMMATICS N.V IMTX | $4.6m0.80% | Reduced -99.0k |
| JANUX THERAPEUTICS INC JANX | $4.3m0.75% | Unchanged |
| EYEPOINT PHARMACEUTICALS INC EYPT | $3.8m0.66% | Reduced -48.0k |
| DECIBEL THERAPEUTICS INC COM | $3.1m0.54% | Unchanged |
| SYROS PHARMACEUTICALS INC SYRS | $2.8m0.49% | Unchanged |
| RAIN ONCOLOGY INC COM | $2.4m0.43% | Reduced -226.1k |
| DAY ONE BIOPHARMACEUTICALS I COM | $2.3m0.41% | Unchanged |
| TANGO THERAPEUTICS INC TNGX | $2.1m0.37% | Unchanged |
| IO BIOTECH INC IOBTQ | $2.0m0.35% | Unchanged |
| LEAP THERAPEUTICS INC CYPH | $1.9m0.33% | New |
| TERNS PHARMACEUTICALS INC COM | $1.8m0.31% | Unchanged |
| IGM BIOSCIENCES INC IGMS | $1.4m0.25% | Unchanged |
| BOLT BIOTHERAPEUTICS INC COM | $1.3m0.24% | Unchanged |
| ELEVATION ONCOLOGY INC COM | $1.3m0.22% | Unchanged |
| VTV THERAPEUTICS INC VTVT | $1.2m0.21% | Unchanged |
| INSTIL BIO INC COM | $985.3k0.17% | Unchanged |
| VIRACTA THERAPEUTICS INC SNSS | $972.5k0.17% | Unchanged |
| ALLAKOS INC ALLKG | $750.3k0.13% | Unchanged |
| AEGLEA BIOTHERAPEUTICS INC AGLE | $398.1k0.07% | Unchanged |
| ALLOVIR INC COM | $279.9k0.05% | Unchanged |
| ASTRIA THERAPEUTICS INC CATB | $208.2k0.04% | Unchanged |
| SCIENCE 37 HOLDINGS INC COM | $191.2k0.03% | Unchanged |
| NOVAVAX INC NVAX | $157.8k0.03% | Unchanged |
| KRONOS BIO INC KRON | $134.4k0.02% | Unchanged |
| NUVATION BIO INC NUVB.WS | $22.1k0.00% | Unchanged |
| SURROZEN INC *W EXP 08/01/203 | $5.5k0.00% | Unchanged |
Sold out since Q1 2023
| Security | Value then |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | $6.5m1.7m shares |
| AMRYT PHARMA PLC | $4.4m304.7k shares |
| ATYR PHARMA INC ATYR | $3.7m1.8m shares |
| INOZYME PHARMA INC | $2.9m504.4k shares |
| ALX ONCOLOGY HLDGS INC ALXO | $1.2m262.8k shares |
| EQUILLIUM INC EQ | $449.3k615.5k shares |
| ATRECA INC BCEL | $299.6k262.8k shares |
| LEAP THERAPEUTICS INC LPTX | $287.7k846.0k shares |
| KALA BIO INC | $181.0k12.0k shares |
| SURROZEN INC | $180.6k300.0k shares |
| NGM BIOPHARMACEUTICALS INC NGM | $55.8k13.7k shares |